Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia.
PMID 41815287 · PMC12971725 · Blood neoplasia · 2026 · 8 claims · 8 setups
EIF4A1 is highly expressed in AML stem- and progenitor-like cells relative to healthy hematopoietic stem/progenitor cells
-
Full-text index only
Decoding drug-responsive cell subpopulations in triple-negative breast cancer using single-cell multiomics.
PMID 42088352 · PMC13138057 · iScience · 2026 · 8 claims · 8 setups
A multimodal framework bridging bulk and single-cell transcriptomics data identifies drug-responsive cell subpopulations in TNBC
-
Full-text index only
Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy.
PMID 42074110 · PMC13115843 · International journal of molecular sciences · 2026 · 8 claims · 8 setups
25 immune-related candidate driver genes were identified from tumor, myeloid, and lymphoid cell gene regulatory networks (GRNs) using SCENIC and topological Q statistics.
-
Full-text index only
Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response.
PMID 41925746 · PMC13046951 · Cancer immunology, immunotherapy : CII · 2026 · 8 claims · 8 setups
A three-step computational framework (ImmCeRNA) identified 6,070 immune-related ceRNA interactions across 27 cancer types by integrating expression correlation and experimental validation data.
-
Full-text index only
Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.
PMID 41037662 · PMC12877751 · Cancer discovery · 2026 · 8 claims · 7 setups
ATAC-seq profiling of osteosarcoma patient samples, PDXs, and PDX-CLs reveals two distinct chromatin accessibility subtypes: early osteoblast-derived (EOD) and late osteoblast-derived (LOD)